Replies to post #1082 on Resverlogix Corp. (RVXCF)

[noretreat]

I think the only plan is survival. Apabetalone has failed two large heavily publicized trials (first one was in 2014). Not by much, but missed primary endpoints equal failure. IMO, they should sell to whoever will make an offer, if anyone comes forward. Otherwise this may go to zero. Where would the $ come from to fund another big trial?

The other related company, Zenith, still has significant value and buyout potential.

But what the heck do I know?

[cabel]

With all that has been shown in the BETonMACE trial and them still holding out on the eGFR data,... I feel positive that once the Covid-19 pandemic has died down,.. they will announce a partner to go forward with the developement of Apabetalone.

I can't see the big investors in this just letting it go to zero with all that has been shown with the drug.